APA (7th ed.) Citation

Fernández-Cancio, M., Camats, N., Flück, C. E., Zalewski, A., Dick, B., Frey, B. M., . . . Pandey, A. V. (2018). Mechanism of the Dual Activities of Human CYP17A1 and Binding to Anti-Prostate Cancer Drug Abiraterone Revealed by a Novel V366M Mutation Causing 17,20 Lyase Deficiency. MDPI AG.

Chicago Style (17th ed.) Citation

Fernández-Cancio, Mónica, et al. Mechanism of the Dual Activities of Human CYP17A1 and Binding to Anti-Prostate Cancer Drug Abiraterone Revealed by a Novel V366M Mutation Causing 17,20 Lyase Deficiency. MDPI AG, 2018.

MLA (8th ed.) Citation

Fernández-Cancio, Mónica, et al. Mechanism of the Dual Activities of Human CYP17A1 and Binding to Anti-Prostate Cancer Drug Abiraterone Revealed by a Novel V366M Mutation Causing 17,20 Lyase Deficiency. MDPI AG, 2018.